| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6157411 | American Journal of Kidney Diseases | 2015 | 9 Pages |
Abstract
Higher adiponectin level is associated with a 3-fold higher death risk in HD patients independent of body composition and lipid levels. Future studies are needed to elucidate underlying mechanisms and determine therapeutic targets associated with improved outcomes in HD patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Connie M. MD, MSc, Danh V. MS, PhD, Hamid MD, Steven M. MD, MSCE, Ramanath MD, Jennie MS, Tracy BA, Csaba P. MD, Gregory A. MD, Kamyar MD, MPH, PhD,